Double-Masked Trial of NOVA22007 (1mg/mL Ciclosporin/Cyclosporine) Versus Vehicle in Pediatric Patients With Active Severe Vernal Keratoconjunctivitis

NCT01751126 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

169

Enrollment

INDUSTRY

Sponsor class

Conditions

Vernal Keratoconjunctivitis

Interventions

DRUG: NOVA22007 ''Ciclosporin''
DRUG: Placebo

Sponsor

Santen SAS